Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer

Makohon-Moore, Alvin P, Zhang, Ming, Reiter, Johannes G, Bozic, Ivana, Allen, Benjamin, Kundu, Deepanjan, Chatterjee, Krishnendu, Wong, Fay +12 more·2017·Nature Genetics
DOI 10.1038/ng.3764

Cited by (411)

Items 401–411 of 411

  1. Elaborating novel and effective treatment for pancreatic cancer
    Wenjun Lan · 2020
  2. Elucidation du rôle de la Ténascine-X dans la progression tumorale : focus sur la carcinogenèse pancréatique
    Sophie Liot · 2021 · theses.fr (ABES)
  3. Développement d’un pipeline d’analyse bioinformatique de l'hétérogénéité clonale de tumeurs afin de prédire les réponses aux traitements des patients atteints de cancer
    Charlotte Andrieu · 2023
  4. Extra-lineage tissue programs define the transcription states of human pancreatic cancer
    Sabrina Ge, Paul Tonon, Jingxiong Xu, Gun-Ho Jang, Ferris Nowlan, Jimin Min, Karen Ng, Eugenia Flores Figueroa, Amy Xin Wei Zhang, Michelle Chan‐Seng‐Yue et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  5. KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53
    Ezequiel J Tolosa, G. L. Raja Arul, Ashley N. Sigafoos, Victoria Ferrero, David R. Pease, Luciana L. Almada, Renzo E Vera, Nicole M. Pena Ruiz, Tara L. Hogenson, Kayla C. LaRue-Nolan et al. · 2026 · Journal of Biological Chemistry
  6. Implications and risk of new versus persisting intraductal papillary mucinous neoplasms after pancreatic surgery: meta-analysis
    Anouk Janine van Bodegraven, Katharina Marstaller, Virginia Padoan, Danhui Heo, Giampaolo Perri, George Louis Burchell, Martin Loos, Christoph W. Michalski, Marc G. Besselink, Umberto Cillo et al. · 2026 · BJS Open
  7. Metastasis-Specific APC Alteration and Nuclear β-Catenin Accumulation in IPMN-Associated Pancreatic Ductal Adenocarcinoma: Genomic Analysis of Matched Precursor, Carcinoma, and Liver Metastasis—A Case Report
    Chang Gok Woo, Kyuri Jo, JunKu Kim, Eung‐Gook Kim, Ok‐Jun Lee · 2026 · Journal of Clinical Medicine
  8. Efficacy of immune checkpoint inhibitors combined with different chemotherapy in recurrent pancreatic cancer: a retrospective study
    Qiang Tao, Lingmin Jiang, Ruiqi Wang, Xin Huang, Pu Xi, Jun Wang, Shengping Li, Chaobin He · 2026 · Frontiers in Immunology
  9. Patient-derived organoids in pancreatic cancer: Advances and applications in precision oncology
    Hee Seung Lee, Bon‐Kyoung Koo · 2026 · Cancer Biome and Targeted Therapy
  10. Clinical metastatic cancer from initiation to colonization: emerging challenges and breakthroughs
    Guanglin Niu, Catharina Hagerling · 2026 · Oncogene
  11. Metastatic pancreatic cancer: from human disease to preclinical modelling
    Jimin Min, Vasiliki Liaki, Peter Y. Yu, Carmen Guerra, Anirban Maitra · 2026 · Gut